RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study

Status unconfirmed · Not applicable

Conditions studied: Pharmacies, Opioid Use, Patient Safety

In brief

This multi-site study will test the efficacy of an intervention to train and equip pharmacists to provide naloxone, an overdose antidote, to patients using prescribed and illicit opioids, to improve opioid safety and prevent opioid-involved adverse events. The study will carry out a stepped-wedge, cluster randomized trial implemented over five waves, within two chain community pharmacies across four states with varying pharmacy-based naloxone distribution laws: Oregon, Washington, Massachusetts, and New Hampshire. Our specific study aims are to: 1) integrate two successful demonstration research projects into one cohesive educational program (MOON+), 2) evaluate the effectiveness of MOON + on naloxone-related outcomes, and 3) use mixed methods to further explore the impact and implementation of MOON+ and associated factors (e.g., state policy, store policy, region).

Key facts

Study ID

NCT03545321

Run by

Brandeis University

People needed

450

Starts

2019-07-09

Expected to finish

2022-11-01

Last updated by the study team

2022-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• English speaking, age 18 years or older, a pharmacist or pharmacy manager employed half time or more by CVS Pharmacy in Massachusetts or New Hampshire or by Albertsons Companies in Washington or Oregon

You may not qualify if…

• none

Where it is running

• Brandeis University — Waltham, Massachusetts, United States
• Comagine Health — Portland, Oregon, United States
• Oregon Health and Sciences University — Portland, Oregon, United States
• University of Rhode Island — Kingston, Rhode Island, United States
• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.